Photo by bundo from unsplash
The Pharmacogene Variation (PharmVar) Consortium is the successor of the Human Cytochrome P450 (CYP) Allele Nomenclature website that served the pharmacogenetics community by designating CYP star (*) alleles. The aim… Click to show full abstract
The Pharmacogene Variation (PharmVar) Consortium is the successor of the Human Cytochrome P450 (CYP) Allele Nomenclature website that served the pharmacogenetics community by designating CYP star (*) alleles. The aim of PharmVar is to continue the mission of serving as an official allele designation authority for the global pharmacogenetics community. Herein, we describe the introduction of the first nonCYP gene to PharmVar. Pharmacogenetic variation of NUDT15 plays a significant role in thiopurine response variability and toxicity.
Journal Title: Clinical Pharmacology and Therapeutics
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!